Atopic dermatitis, also known as atopic eczema, is a prevalent chronic inflammatory skin condition affecting a substantial number of individuals worldwide. It is characterized by dry, itchy, and inflamed skin, leading to significant discomfort and diminished quality of life for those affected. To comprehensively understand the pathogenesis and advance therapeutic approaches for atopic dermatitis, it is essential to bridge the gap between laboratory-based research (the "bench") and clinical practice (the "bedside"). The "bench" aspect entails laboratory investigations, experimental studies, cell cultures, animal models, and molecular research aimed at unravelling the intricate mechanisms underlying the development and progression of atopic dermatitis. On the other hand, the "bedside" component encompasses the clinical aspects, focusing on the diagnosis, treatment, and management of atopic dermatitis in real-world patient settings.
This Research Topic aims to establish a connection between laboratory research and clinical practice in the field of atopic dermatitis, encompassing scientific advancements in understanding the molecular mechanisms and immunological aspects of the condition at the bench, as well as the translation of this knowledge into clinical practice at the bedside. By examining the latest research findings and clinical approaches, we intend to provide valuable insights into the comprehensive management of atopic dermatitis, ultimately improving patient prognosis and enhancing our understanding of this complex skin disorder.
The scope of this Research Topic includes a comprehensive exploration of atopic dermatitis, with a particular focus on the transition from bench to bedside. We invite authors to contribute Original Research articles, Review papers, Clinical Case studies, and Perspectives that address key themes within this field. Specific areas of interest include, but are not limited to:
• Molecular and cellular mechanisms underlying the pathogenesis of atopic dermatitis.
• Immune dysregulation and inflammatory processes involved in the development and progression of the condition.
• Novel experimental models and technological advances for studying atopic dermatitis.
• Identification of biomarkers for diagnosis, prognosis, and treatment response prediction.
• Development and evaluation of therapeutic strategies, including topical agents, systemic treatments, immunomodulatory approaches, and emerging therapies.
• Multidisciplinary approaches for comprehensive patient management, encompassing patient education, psychosocial aspects, and lifestyle modifications.
By encouraging contributions across these themes, we aim to provide a comprehensive overview of the current state of research and clinical practice in atopic dermatitis, fostering a deeper understanding of the disease and its management for the benefit of patients and healthcare professionals alike.
Atopic dermatitis, also known as atopic eczema, is a prevalent chronic inflammatory skin condition affecting a substantial number of individuals worldwide. It is characterized by dry, itchy, and inflamed skin, leading to significant discomfort and diminished quality of life for those affected. To comprehensively understand the pathogenesis and advance therapeutic approaches for atopic dermatitis, it is essential to bridge the gap between laboratory-based research (the "bench") and clinical practice (the "bedside"). The "bench" aspect entails laboratory investigations, experimental studies, cell cultures, animal models, and molecular research aimed at unravelling the intricate mechanisms underlying the development and progression of atopic dermatitis. On the other hand, the "bedside" component encompasses the clinical aspects, focusing on the diagnosis, treatment, and management of atopic dermatitis in real-world patient settings.
This Research Topic aims to establish a connection between laboratory research and clinical practice in the field of atopic dermatitis, encompassing scientific advancements in understanding the molecular mechanisms and immunological aspects of the condition at the bench, as well as the translation of this knowledge into clinical practice at the bedside. By examining the latest research findings and clinical approaches, we intend to provide valuable insights into the comprehensive management of atopic dermatitis, ultimately improving patient prognosis and enhancing our understanding of this complex skin disorder.
The scope of this Research Topic includes a comprehensive exploration of atopic dermatitis, with a particular focus on the transition from bench to bedside. We invite authors to contribute Original Research articles, Review papers, Clinical Case studies, and Perspectives that address key themes within this field. Specific areas of interest include, but are not limited to:
• Molecular and cellular mechanisms underlying the pathogenesis of atopic dermatitis.
• Immune dysregulation and inflammatory processes involved in the development and progression of the condition.
• Novel experimental models and technological advances for studying atopic dermatitis.
• Identification of biomarkers for diagnosis, prognosis, and treatment response prediction.
• Development and evaluation of therapeutic strategies, including topical agents, systemic treatments, immunomodulatory approaches, and emerging therapies.
• Multidisciplinary approaches for comprehensive patient management, encompassing patient education, psychosocial aspects, and lifestyle modifications.
By encouraging contributions across these themes, we aim to provide a comprehensive overview of the current state of research and clinical practice in atopic dermatitis, fostering a deeper understanding of the disease and its management for the benefit of patients and healthcare professionals alike.
